Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates

Genetics in Medicine(2021)10.1016/j.gim.2021.10.010Source: DataRank Database

Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates is a research paper published in Genetics in Medicine (2021). On theSindex it has a DataRank of 0.494. It has been cited 26 times.

N/A

0.494DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

dbgap doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 4.27)OA: greenTopics (35)Linked Datasets (20)DataCite Reuse (20)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.494

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (17)

Wanfeng Yu ORCID,Andrea M. Oza ORCID,Megan Hawley ORCID,Prathik K. Vijay Kumar,Christopher Koch ORCID

Live enrichment

PubMed:34906510 PMC:PMC10128874 OpenAlex:https://openalex.org/W3215310926

National Institutes of Health

Grant: U01HG008701

National Institutes of Health

Grant: U01HG008679

National Institutes of Health

Grant: U01HG008685

National Institutes of Health

Grant: U01HG008666

National Institutes of Health

Grant: U01HG008676

National Institutes of Health

Grant: U01HG008657

Vanderbilt University Medical Center

Grant: 2015P000929

National Institutes of Health

Grant: 3U01HG008676-04S2

EMERGE III CENTRAL SEQUENCING, GENOTYPING AND INTERPRETATION FACILITY

National Institutes of Health

Grant: 5U01HG008657-10

eMERGE IV Northwest: A partnership to evaluate the use of genomic information in the health care of diverse participants

National Institutes of Health

Grant: 1U01HG008685-01

EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE

National Institutes of Health

Grant: 5U01HG008679-04

EMR-Linked Biobank for Translational Genomics

National Institutes of Health

Grant: 6U01HG008701-02

The Electronic Medical Records and Genomics (eMERGE) Network Phase III - Coordinating Center (U01)

National Institutes of Health

Grant: 5U01HG008666-03

Better Outcomes for Children: Promoting Excellence in Healthcare Genomics to Inform Policy

National Human Genome Research Institute

FWCI

4.27

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Elsevier Non-Commercial

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10128874/pdf/nihms-1878467.pdf

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128874

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10128874/pdf/nihms-1878467.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1098360021053600?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1098360021053600?httpAccept=text/plain

Fields of Study

Genomics and Rare DiseasesElectronic Health Records SystemsGenetic Associations and EpidemiologyMedicineComputer Science0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Genetic TestingHumansGenetic VariationGenetic Predisposition to DiseaseGenomics

Keywords

GenomicsMedical geneticsSequence (biology)Clinical PracticeMedical recordMedicineBioinformaticsComputational biologyBiologyFamily medicineGeneticsInternal medicineGenomeGeneEmergeVariant ReclassificationAutomated Variant Reclassification AlertsVariant Reassessment FrameworkGenetic VariationHumansGenetic Predisposition to DiseaseGenetic Testing

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Industry, innovation and infrastructure

Additional file 4 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

10.6084/m9.figshare.20495869.v1figshare

Additional file 4 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

10.6084/m9.figshare.20495869figshare

Additional file 2 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.24670323.v1figshare

Additional file 2 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.24670323figshare

Additional file 6 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.26647053.v1figshare

Additional file 6 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.26647053figshare

Additional file 3 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.26647044.v1figshare

Additional file 4 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.26647047figshare

Additional file 4 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.26647047.v1figshare

Additional file 5 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.26647050.v1figshare

Additional file 5 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.26647050figshare

Additional file 1 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.24670002.v1figshare

Additional file 3 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.26647044figshare

Additional file 1 of Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity

10.6084/m9.figshare.24670002figshare

Additional file 1 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

10.6084/m9.figshare.20495860.v1figshare

Additional file 3 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

10.6084/m9.figshare.20495866.v1figshare

Additional file 2 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

10.6084/m9.figshare.20495863figshare

Additional file 1 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

10.6084/m9.figshare.20495860figshare

Additional file 2 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

10.6084/m9.figshare.20495863.v1figshare

Additional file 3 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

10.6084/m9.figshare.20495866figshare

Related Papers (10)

Integrated analysis of metabolomic profiling and exome data supplements sequence variant interpretation, classification, and diagnosis

Genetics in Medicine(2020)

co-citedsame journal

10.1038/s41436-020-0827-0

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

N/A

1.6DataRank · unranked

Genetics in Medicine(2015)

co-citedsame journal

10.1038/gim.2015.30

An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome

Circulation(2020)

co-cited

10.1161/circulationaha.119.043132

Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies

The American Journal of Human Genetics(2020)

co-cited

10.1016/j.ajhg.2020.09.011

Changes in genetic variant results over time in pediatric cardiomyopathy and electrophysiology

N/A

0.449DataRank · unranked

Journal of Genetic Counseling(2020)

co-cited

10.1002/jgc4.1313

Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study

N/A

1.2DataRank · unranked

Circulation(2021)

co-cited

10.1161/circulationaha.121.055562

Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

Clinical Cancer Research(2022)

co-cited

10.1158/1078-0432.ccr-22-0203

ClinVar: public archive of relationships among sequence variation and human phenotype

Top 1%

13.2DataRank

Nucleic Acids Research(2013)

co-cited

10.1093/nar/gkt1113

A global reference for human genetic variation

Top 1%

10.6DataRank

Nature(2015)

co-cited

10.1038/nature15393

Analysis of protein-coding genetic variation in 60,706 humans

Top 1%

13.0DataRank

Nature(2016)

co-cited

10.1038/nature19057

Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates

FAIR Checklist

DataRank Breakdown

Authors (17)

Funding (14 grants)

Impact

Open Access

Topics

Linked Datasets (20)

Annotations (Europe PMC)

Related Papers (10)